Sort
172,184 grants matching “inflammation”
Development of DYRK1A allosteric modulator for the treatment of Alzheimer's Disease
$976,999Gian Luca Araldi · Avanti Biosciences, Inc. · SB1 · FY2022 · AG
INNOVATIVE CELL-BASED URINALYSIS FOR PATIENT ADHERENCE
$976,979Rama P Ramanujam · Swaasth, Inc. · R44 · FY2009 · AT
The Role of Group 3 Innate Lymphoid cells (ILC3) in Tuberculosis
$976,790Shabaana A. Khader · Washington University · R01 · FY2018 · AI
A Precision Medicine for Alcohol-Associated Liver Disease
$976,742Wanqing Liu · Genetobe Inc. · UT2 · FY2023 · AA
AADRC -- Mechanisms of Virus-Induced Asthma
$976,692University Of Wisconsin Madison · P01 · FY2002 · AI
Aerosol Delivery of Surfactant for ARDS
$976,638Donovan Byron Yeates · Kaer Biotherapeutics Corporation · R44 · FY2019 · HL
Study of the Care and Outcomes of REnal Insufficiency
$976,511Alan S Go · Kaiser Foundation Research Institute · U01 · FY2007 · DK
Screening strategies and social determinants of health among people with high risk of anal cancer
$976,498Lisa C Flowers · Emory University · R01 · FY2024 · CA
IND Enabling Studies and Manufacturing Scale Up of Human Placental Extract to Prevent Surgical Necrotizing Enterocolitis
$976,322Michael Bentley Berger · Plakous Therapeutics, Inc. · R44 · FY2025 · HD
Preeclampsia and the Brain: Small vessel disease and cognitive function in early midlife
$976,170Janet M Catov · Magee-Women'S Res Inst And Foundation · R01 · FY2025 · AG
Targeting a Novel Regulator of Brain Aging and Alzheimer's Disease
$976,136Bruce A Yankner · Harvard Medical School · R01 · FY2016 · AG
Understanding and Addressing Cancer Health Disparities in Louisiana
$976,081Augusto C Ochoa · Lsu Health Sciences Center · P20 · FY2018 · CA
A Novel Glycosaminoglycan-Based Therapeutic for Chronic Rhinosinusitis
$976,018Justin Rodney Savage · Glycomira, Llc · R44 · FY2022 · AI
Gene Therapy and Hematopoietic Stem Cell Research to Treat Inherited Primary Immune Deficiencies
$976,015Harry L Malech · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Enhancing Dental and Craniomaxillofacial Surgery Outcomes with Cost-Effective and Scalable Animal-Free Amino Acid-Based Membranes for Guided Bone Regeneration
$976,000Sherif Soliman · Matregenix · R44 · FY2025 · DE
UTEP-UNM HSC ARCH PROGRAM ON BORDER ASTHMA
$975,967Nicholas E Pingitore · University Of Texas El Paso · S11 · FY2006 · ES
Clinical Utility of Endothelial Function in PAD
$975,965Noyan Gokce · Boston Medical Center · R01 · FY2006 · HL
Development of a Technology Platform for Engineering Single-Administration HIV Therapeutics
$975,928Leor S Weinberger · J. David Gladstone Institutes · R56 · FY2019 · AI
Human Translational Studies of Vascular Thrombosis and Inflammation
$975,922Yogendra Kanthi · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
Unraveling Cytotoxic and Thrombotic Signals in COVID-19
$975,922Yogendra Kanthi · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
Effects of Multi-Modal Exercise Intervention Post Hip Fracture
$975,857Jay Steven Magaziner · University Of Maryland Baltimore · R37 · FY2013 · AG
Impact of IL-15 immunotherapy on tissue-specific CD8 T cells to reduce the CNS HIV reservoir seeding and persistence
$975,768Lydie Trautmann · Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2024 · MH
Determinants of the racial/ethnic disparity in MGUS risk: An epidemiologic study in 4 cohorts
$975,742Wendy Cozen · University Of California-Irvine · R01 · FY2021 · CA
Role of inflammation, innate resistance, and immunity in carcinogenesis.
$975,704Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Harnessing engineered T regulatory cells to promote beta cell health in T1D
$975,699Jane Hoyt Buckner · Benaroya Research Inst At Virginia Mason · R01 · FY2024 · DK